19 VESTRY STREET, NEW YORK, NY
Market cap: $606.6M (2/12/2026)
Price: $77.90
Management's Discussion and Analysis for the First Quarter Ended December 31, 2025
ANNOUNCES CLOSING OF US$175 MILLION PUBLIC OFFERING
Registration Statement on Form F-3
And Piper Sandler & Co. Terminate Equity Distribution Agreement
ANNOUNCES LAUNCH OF US$100 MILLION PUBLIC OFFERING
Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
To Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026
Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
No filings found
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Free Writing Prospectus